These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 10331413

  • 1. Hepatic insulin resistance and defects in substrate utilization in cystic fibrosis.
    Hardin DS, LeBlanc A, Para L, Seilheimer DK.
    Diabetes; 1999 May; 48(5):1082-7. PubMed ID: 10331413
    [Abstract] [Full Text] [Related]

  • 2. Elevated gluconeogenesis and lack of suppression by insulin contribute to cystic fibrosis-related diabetes.
    Hardin DS, Ahn C, Rice J, Rice M, Rosenblatt R.
    J Investig Med; 2008 Mar; 56(3):567-73. PubMed ID: 18418124
    [Abstract] [Full Text] [Related]

  • 3. The metabolic effects of pregnancy in cystic fibrosis.
    Hardin DS, Rice J, Cohen RC, Ellis KJ, Nick JA.
    Obstet Gynecol; 2005 Aug; 106(2):367-75. PubMed ID: 16055589
    [Abstract] [Full Text] [Related]

  • 4. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.
    Groop LC, Bonadonna RC, DelPrato S, Ratheiser K, Zyck K, Ferrannini E, DeFronzo RA.
    J Clin Invest; 1989 Jul; 84(1):205-13. PubMed ID: 2661589
    [Abstract] [Full Text] [Related]

  • 5. Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction.
    Yung B, Noormohamed FH, Kemp M, Hooper J, Lant AF, Hodson ME.
    Diabet Med; 2002 Mar; 19(3):221-6. PubMed ID: 11963922
    [Abstract] [Full Text] [Related]

  • 6. Assessment of hepatic insulin action in obese type 2 diabetic patients.
    Staehr P, Hother-Nielsen O, Levin K, Holst JJ, Beck-Nielsen H.
    Diabetes; 2001 Jun; 50(6):1363-70. PubMed ID: 11375337
    [Abstract] [Full Text] [Related]

  • 7. Roles of insulin resistance and beta-cell dysfunction in the pathogenesis of glucose intolerance in cystic fibrosis.
    Austin A, Kalhan SC, Orenstein D, Nixon P, Arslanian S.
    J Clin Endocrinol Metab; 1994 Jul; 79(1):80-5. PubMed ID: 8027259
    [Abstract] [Full Text] [Related]

  • 8. Chronic physiologic hyperinsulinemia impairs suppression of plasma free fatty acids and increases de novo lipogenesis but does not cause dyslipidemia in conscious normal rats.
    Koopmans SJ, Kushwaha RS, DeFronzo RA.
    Metabolism; 1999 Mar; 48(3):330-7. PubMed ID: 10094109
    [Abstract] [Full Text] [Related]

  • 9. Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes.
    Felber JP, Ferrannini E, Golay A, Meyer HU, Theibaud D, Curchod B, Maeder E, Jequier E, DeFronzo RA.
    Diabetes; 1987 Nov; 36(11):1341-50. PubMed ID: 3311856
    [Abstract] [Full Text] [Related]

  • 10. Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.
    Henriksen JE, Levin K, Thye-Rønn P, Alford F, Hother-Nielsen O, Holst JJ, Beck-Nielsen H.
    Diabetes; 2000 Jul; 49(7):1209-18. PubMed ID: 10909980
    [Abstract] [Full Text] [Related]

  • 11. MARKEDLY DELAYED INSULIN SECRETION AND A HIGH RATE OF UNDETECTED OVERT DIABETES CHARACTERIZE GLUCOSE METABOLISM IN ADULT PATIENTS WITH CYSTIC FIBROSIS AFTER LUNG TRANSPLANTATION.
    Winhofer Y, Wolf P, Fellinger P, Tura A, Hillebrand P, Staufer K, Trauner M, Jaksch P, Muraközy G, Kautzky-Willer A, Pacini G, Krebs M, Luger A, Kazemi-Shirazi L.
    Endocr Pract; 2019 Mar; 25(3):254-262. PubMed ID: 30913015
    [Abstract] [Full Text] [Related]

  • 12. Mechanisms of insulin resistance in cystic fibrosis.
    Hardin DS, Leblanc A, Marshall G, Seilheimer DK.
    Am J Physiol Endocrinol Metab; 2001 Nov; 281(5):E1022-8. PubMed ID: 11595659
    [Abstract] [Full Text] [Related]

  • 13. Insulin resistance is associated with decreased clinical status in cystic fibrosis.
    Hardin DS, LeBlanc A, Lukenbough S, Seilheimer DK.
    J Pediatr; 1997 Jun; 130(6):948-56. PubMed ID: 9202618
    [Abstract] [Full Text] [Related]

  • 14. Proteolysis associated with insulin resistance in cystic fibrosis.
    Hardin DS, LeBlanc A, Lukenbaugh S, Para L, Seilheimer DK.
    Pediatrics; 1998 Mar; 101(3 Pt 1):433-7. PubMed ID: 9481010
    [Abstract] [Full Text] [Related]

  • 15. The 1-h oral glucose tolerance test glucose and insulin values are associated with markers of clinical deterioration in cystic fibrosis.
    Coriati A, Ziai S, Lavoie A, Berthiaume Y, Rabasa-Lhoret R.
    Acta Diabetol; 2016 Jun; 53(3):359-66. PubMed ID: 26215312
    [Abstract] [Full Text] [Related]

  • 16. Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis.
    Hammana I, Malet A, Costa M, Brochiero E, Berthiaume Y, Potvin S, Chiasson JL, Coderre L, Rabasa-Lhoret R.
    Diabetes Metab; 2007 Jun; 33(3):213-9. PubMed ID: 17418606
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms of glucose intolerance in cystic fibrosis.
    Mohan K, Miller H, Dyce P, Grainger R, Hughes R, Vora J, Ledson M, Walshaw M.
    Diabet Med; 2009 Jun; 26(6):582-8. PubMed ID: 19538232
    [Abstract] [Full Text] [Related]

  • 18. Insulin sensitivity in cystic fibrosis.
    Moran A, Pyzdrowski KL, Weinreb J, Kahn BB, Smith SA, Adams KS, Seaquist ER.
    Diabetes; 1994 Aug; 43(8):1020-6. PubMed ID: 8039595
    [Abstract] [Full Text] [Related]

  • 19. Reduced non-oxidative glucose utilization in cancer patients is associated with a low triiodothyronine concentration.
    Tayek JA.
    J Am Coll Nutr; 1995 Aug; 14(4):341-8. PubMed ID: 8568110
    [Abstract] [Full Text] [Related]

  • 20. Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus.
    Perriello G, Misericordia P, Volpi E, Pampanelli S, Santeusanio F, Brunetti P, Bolli GB.
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2464-9. PubMed ID: 7629243
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.